GHK-Cu Dosing & Protocols — Research Reference
Reconstitution math, topical vs injectable dosing ranges, scheduling, and copper-saturation considerations from the GHK-Cu research literature.
GHK-Cu Dosing & Protocols — Research Reference
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) extensively studied across wound healing, hair follicle, anti-fibrotic, and cosmetic-research models. Dosing varies sharply by route of administration.
Reconstitution for Research
GHK-Cu is typically supplied as a deep-blue lyophilized powder (the copper chromophore confirms intact coordination). A 50 mg vial reconstituted with 5 mL bacteriostatic water yields 10 mg/mL. For topical research, dilution into a carrier base (often 1–3 mg per mL of vehicle) is standard. Reconstituted aqueous solution is stable refrigerated for 30+ days; topical formulations should be batched in opaque containers because GHK-Cu is light-sensitive.
Reference Dose Ranges in Published Research
| Route | Typical range | Notes | |---|---|---| | Topical (skin / scalp models) | 0.05%–0.2% (w/v) in carrier | Most-cited tier across cosmetic and follicle research | | Subcutaneous (systemic models) | 1–3 mg per dose | Used in wound, anti-fibrotic, and systemic gene-expression studies | | Intradermal (localized) | 100–500 mcg per site | Localized fibroblast and follicle studies |
Scheduling
Topical protocols use once- or twice-daily application to the model site. Subcutaneous research typically runs once daily; some wound-model studies use every-other-day dosing because GHK-Cu signalling produces durable gene-expression changes that persist beyond plasma clearance. Cycling is rarely reported because tolerance/receptor downregulation has not been described.
Copper Saturation and Identity
GHK-Cu's mechanism depends on intact copper coordination. Material that has lost the copper ion (visible as fading of the blue color) reverts to free GHK and behaves differently in published models. Mass-spec confirmation should show the copper-saturated mass (M+62 vs free GHK at 340.4 Da). UV-Vis absorbance with a peak around 525 nm is the standard confirmation of intact Cu-coordination.
Quality Verification
HPLC purity ≥98% and ICP-MS or AAS confirmation of stoichiometric copper content (1:1 mol/mol) are the most-cited acceptance criteria. Endotoxin testing applies for parenteral animal models.
Research Use Only. All content is for laboratory research and educational reference. Compounds discussed are not intended for human or veterinary consumption, prophylactic, or therapeutic use.
References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- Hostynek JJ, Dreher F, Maibach HI. Human stratum corneum penetration by copper: in vivo study after occlusive and semi-occlusive application of the metal as powder. Food Chem Toxicol. 2006;44(9):1539–1543.
Related Research Articles
Sermorelin Research Guide — GHRH Analog Mechanism & Dosing
Sermorelin is a 29-amino-acid fragment of growth hormone-releasing hormone (GHRH), studied for its capacity to stimulate pulsatile, physiologic GH release while preserving the pituitary's natural negative feedback regulation — a mechanistic distinction that separates it from direct GH administration and positions it alongside CJC-1295 and Tesamorelin in GHRH analog research.
Cagrilintide Dosing & Protocols — Research Reference
Reference dose tiers, titration ladder, reconstitution math, and semaglutide co-administration scheduling from the published cagrilintide (amylin analogue) research record.
Hexarelin Dosing & Protocols — Research Reference
Reference dose tiers, reconstitution math, scheduling, and receptor-desensitization considerations from the hexarelin research literature.
GHRP-2 Dosing & Protocols — Research Reference
Reference dose tiers, reconstitution math, and GHRH co-administration scheduling drawn from the published GHRP-2 (pralmorelin) research record.
Survodutide Dosing & Protocols — Research Reference
Reference dose tiers, titration ladder, reconstitution math, and weekly-injection scheduling from the published survodutide (GLP-1/glucagon dual agonist) research record.
GHRP-6 Dosing & Protocols — Research Reference
Reference dose tiers, reconstitution math, scheduling, and the appetite-stimulus considerations that distinguish GHRP-6 in published research.
Related Research Materials
Parent Research Hubs
Neutral, moderated research discussion. Laboratory use only.
More compound guides, hubs, and educational research materials.